Use of the Dexamethasone Suppression Test on a Combined Medicine-Psychiatry Inpatient Unit

Publisher Website
Google Scholar
Abstract
The dexamethasone suppression test (DST) appears to be a sensitive and specific biological marker for endogenous depression that can have important diagnostic and treatment implications. The authors present three case studies of patients treated on a combined medicine-psychiatric inpatient unit, and who presented with complex psychobiological illnesses. They discuss the usefulness of the DST in the hospital management of these patients from a diagnostic and treatment perspective.